Skip to main content
Premium Trial:

Request an Annual Quote

University of Liverpool, Liverpool School of Tropical Medicine Win $4.5M Antimicrobial Resistance Grant

NEW YORK — The University of Liverpool and the Liverpool School of Tropical Medicine (LSTM) have been awarded a £3.5 million ($4.5 million) grant from the UK's National Institute for Health Research to develop a personalized approach to infectious disease treatment to help combat antimicrobial resistance (AMR), the university said this week.

With the funding, the University of Liverpool and LSTM will purchase equipment for real-time measurement of drug concentrations in patients, rapid sequencing of bacteria from patients, pharmacogenetic analyses, and real-time pharmacodynamic analyses. These technologies will be used in combination with artificial intelligence and deep learning, the university said.

"Our goal is to find ways to move away from a one-size-fits-all to a fully individualized approach where each patient receives the right drug and dose for their infection and knows whether they are well positioned to receive maximum effect from their antimicrobial therapy," University of Liverpool researcher William Hope said in a statement. "Liverpool is building the infrastructure and knowledge to prevent AMR from occurring and to provide treatment options for patients that have few and sometimes no treatment options."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.